NDC 63187-382

Medroxyprogesterone Acetate

Medroxyprogesterone Acetate

Medroxyprogesterone Acetate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Proficient Rx Lp. The primary component is Medroxyprogesterone Acetate.

Product ID63187-382_2d5e3f56-706b-4929-8067-8beb9090bc89
NDC63187-382
Product TypeHuman Prescription Drug
Proprietary NameMedroxyprogesterone Acetate
Generic NameMedroxyprogesterone Acetate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1996-12-04
Marketing CategoryANDA / ANDA
Application NumberANDA040159
Labeler NameProficient Rx LP
Substance NameMEDROXYPROGESTERONE ACETATE
Active Ingredient Strength10 mg/1
Pharm ClassesProgesterone Congeners [CS],Progestin [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 63187-382-10

10 TABLET in 1 BOTTLE (63187-382-10)
Marketing Start Date2019-02-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63187-382-20 [63187038220]

Medroxyprogesterone Acetate TABLET
Marketing CategoryANDA
Application NumberANDA040159
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-09-01

NDC 63187-382-10 [63187038210]

Medroxyprogesterone Acetate TABLET
Marketing CategoryANDA
Application NumberANDA040159
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-02-01

NDC 63187-382-90 [63187038290]

Medroxyprogesterone Acetate TABLET
Marketing CategoryANDA
Application NumberANDA040159
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-01

NDC 63187-382-30 [63187038230]

Medroxyprogesterone Acetate TABLET
Marketing CategoryANDA
Application NumberANDA040159
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-09-01

NDC 63187-382-60 [63187038260]

Medroxyprogesterone Acetate TABLET
Marketing CategoryANDA
Application NumberANDA040159
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-01

NDC 63187-382-40 [63187038240]

Medroxyprogesterone Acetate TABLET
Marketing CategoryANDA
Application NumberANDA040159
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-01

Drug Details

Active Ingredients

IngredientStrength
MEDROXYPROGESTERONE ACETATE10 mg/1

OpenFDA Data

SPL SET ID:0df6fd1e-7d9c-4a38-848c-1e562e211c91
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1000114
  • Pharmacological Class

    • Progesterone Congeners [CS]
    • Progestin [EPC]
    • Progesterone Congeners [CS]
    • Progestin [EPC]

    NDC Crossover Matching brand name "Medroxyprogesterone Acetate" or generic name "Medroxyprogesterone Acetate"

    NDCBrand NameGeneric Name
    0548-5400Medroxyprogesterone AcetateMedroxyprogesterone acetate
    0548-5410Medroxyprogesterone AcetateMedroxyprogesterone acetate
    68071-1818Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    68071-1870Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    68071-2175Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    68071-4132Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    68071-4666Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    68788-7401Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    68788-9233medroxyprogesterone acetatemedroxyprogesterone acetate
    68788-9899Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    69189-3741medroxyprogesterone acetatemedroxyprogesterone acetate
    69097-539MEDROXYPROGESTERONE ACETATEMEDROXYPROGESTERONE ACETATE
    69189-3740medroxyprogesterone acetatemedroxyprogesterone acetate
    0548-5701Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    0555-0779Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    0555-0873Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    0555-0872Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    70518-0443medroxyprogesterone acetatemedroxyprogesterone acetate
    70518-1932medroxyprogesterone acetatemedroxyprogesterone acetate
    71205-118Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    0703-6801Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    10544-001Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    10544-062Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    21695-896Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    33261-609Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    33261-534Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    33261-740Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    43063-438medroxyprogesterone acetatemedroxyprogesterone acetate
    50090-0883medroxyprogesterone acetatemedroxyprogesterone acetate
    50090-0166Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    50090-0490Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    50090-0491Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    50090-3328medroxyprogesterone acetatemedroxyprogesterone acetate
    52125-915medroxyprogesterone acetatemedroxyprogesterone acetate
    53002-3570Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    55289-816medroxyprogesterone acetatemedroxyprogesterone acetate
    55289-160Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    55289-908medroxyprogesterone acetatemedroxyprogesterone acetate
    55700-699medroxyprogesterone acetatemedroxyprogesterone acetate
    59762-0055medroxyprogesterone acetatemedroxyprogesterone acetate
    59762-3740medroxyprogesterone acetatemedroxyprogesterone acetate
    59762-3742medroxyprogesterone acetatemedroxyprogesterone acetate
    59762-4538medroxyprogesterone acetatemedroxyprogesterone acetate
    59762-3741medroxyprogesterone acetatemedroxyprogesterone acetate
    59762-4537medroxyprogesterone acetatemedroxyprogesterone acetate
    60687-105Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    63187-382Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    63629-2612Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    63629-2614Medroxyprogesterone AcetateMedroxyprogesterone Acetate
    63629-6812Medroxyprogesterone AcetateMedroxyprogesterone Acetate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.